Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients

Journal of Cachexia, Sarcopenia and Muscle

Volumn 7, Issue 1, 2016, Pages 37-47

  Batista, Miguel L ^a,b   Henriques, Felipe S ^a   Neves, Rodrigo X ^a,b   Olivan, Mireia R ^b   Matos Neto, Emídio M ^b   Alcântara, Paulo S M ^b   Maximiano, Linda F ^b   Otoch, José P ^b   Alves, Michele J ^b   Seelaender, Marília ^b  

^a UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adipose tissue; Extracellular matrix; Fibrosis, Inflammation, Cachexia

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CACHEXIA; CANCER PATIENT; CELL INFILTRATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DIGESTIVE SYSTEM CANCER; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MORPHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WEIGHT CHANGE;

EID: 84961616346     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12037     Document Type: Article

References (51)

1. Argiles JM, Anker SD, Evans WJ, Morley JE, Fearon KC, Strasser F, et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010; 11: 229-230.
2. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
3. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002; 2: 862-871.
4. Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 2013; 10: 90-99.
5. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011; 62: 265-279.
6. Argiles JM, Orpi M, Busquets S, Lopez-Soriano FJ. Myostatin: more than just a regulator of muscle mass. Drug Discov Today 2012; 17: 702-709.
7. Arner P. Medicine. Lipases in cachexia. Science 2011; 333: 163-164.
8. Das SK, Hoefler G. The role of triglyceride lipases in cancer associated cachexia. Trends Mol Med 2013; 19: 292-301.
9. Batista ML Jr, Neves RX, Peres SB, Yamashita AS, Shida CS, Farmer SR, Seelaender M. Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia. J Endocrinol 2012; 215: 363-373.
10. Batista ML Jr, Olivan M, Alcantara PS, Sandoval R, Peres SB, Neves RX, Silverio R, Maximiano LF, Otoch JP, Seelaender M. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine 2013; 61: 532-539.
11. Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res 2007; 67: 5531-5537.
12. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89: 381-410.
13. Ryden M, Andersson DP, Bernard S, Spalding K, Arner P. Adipocyte triglyceride turnover and lipolysis in lean and overweight subjects. J Lipid Res 2013; 54: 2909-2913.
14. Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 2011; 333: 233-238.
15. Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab 2014; 20: 433-447.
16. Beluzi M, Peres SB, Henriques FS, Sertie RA, Franco FO, Santos KB, et al. Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. PLoS One 2015; 10: e0122660.
17. Tsoli M, Robertson G. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol Metab 2013; 24: 174-183.
18. Seelaender M, Batista M Jr, Lira F, Silverio R, Rossi-Fanelli F. Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?). Clin Nutr 2012; 31: 562-566.
19. Pond CM Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 17-30.
20. Divoux A, Tordjman J, Lacasa D, Veyrie N, Hugol D, Aissat A, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010; 59: 2817-2825.
21. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101.
22. Hotamisligil GS Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 2008; 32: S52-54.
23. Pierleoni C, Verdenelli F, Castellucci M, Cinti S. Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem 1998; 42: 183-188.
24. Wynn TA Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524-529.
25. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009; 29: 1575-1591.
26. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
27. Kwon SJ. Evaluation of the 7th UICC TNM staging system of gastric cancer. J Gastric Cancer 2011; 11: 78-85.
28. Bohle A. Change of paradigms in nephrology--a view back and a look forward. Nephrol Dial Transplant 1998; 13: 556-563.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
30. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799.
31. Fearon KC, Voss AC, Hustead DS. Cancer cachexia study G: definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345-1350.
32. Batista ML Jr, Peres SB, McDonald ME, Alcantara PS, Olivan M, Otoch JP, et al. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine 2012; 57: 9-16.
33. Arner P. Introduction: the inflammation orchestra in adipose tissue. J Intern Med 2007; 262: 404-407.
34. Bing C, Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care 2008; 11: 201-207.
35. Bing C. Lipid mobilization in cachexia: mechanisms and mediators. Curr Opin Support Palliat Care 2011; 5: 356-360.
36. Ryden M, Agustsson T, Laurencikiene J, Britton T, Sjolin E, Isaksson B, et al. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia. Cancer 2008; 113: 1695-1704.
37. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
38. Dahlman I, Arner P. Genetics of adipose tissue biology. Prog Mol Biol Transl Sci 2010; 94: 39-74.
39. Bing C, Russell S, Becket E, Pope M, Tisdale MJ, Trayhurn P, et al. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer 2006; 95: 1028-1037.
40. Cox TR, Erler JT Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 2011; 4: 165-178.
41. Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 2014; 19: 512-526.
42. Kolehmainen M, Salopuro T, Schwab US, Kekalainen J, Kallio P, Laaksonen DE, et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes (Lond) 2008; 32: 292-303.
43. Ciangura C, Bouillot JL, Lloret-Linares C, Poitou C, Veyrie N, Basdevant A, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring) 2010; 18: 760-765.
44. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-Millo M, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008; 9: R14.
45. Mutch DM, Tordjman J, Pelloux V, Hanczar B, Henegar C, Poitou C, et al. Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles. Am J Clin Nutr 2009; 89: 51-57.
46. Machado AP, Costa Rosa LF, Seelaender MC. Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltration. Cell Tissue Res 2004; 318: 503-514.
47. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
48. Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49: 1894-1903.
49. van Eijk M, Aten J, Bijl N, Ottenhoff R, van Roomen CP, Dubbelhuis PF, et al. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. PLoS One 2009; 4: e4723.
50. Bertevello PS, Seelaender MC. Heterogeneous response of adipose tissue to cancer cachexia. Braz J Med Biol Res 2001; 34: 1161-1167.
51. Kemik O, Kemik AS, Begenik H, Erdur FM, Emre H, Sumer A, et al. The relationship among acute-phase response proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. Hum Exp Toxicol 2012; 31: 117-125.